LongView Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Sell
175
-3
-2% -$3.54K 0.05% 228
2026
Q2
$213K Buy
+178
New +$182K 0.05% 219
2026
Q1
– Sell
-461
Closed -$498K – 262
2025
Q4
$498K Buy
461
+29
+7% +$27.7K 0.12% 144
2025
Q3
$329K Buy
432
+3
+0.7% +$2.23K 0.09% 161
2025
Q2
$334K Sell
429
-2
-0.5% -$1.55K 0.1% 156
2025
Q1
$356K Sell
431
-3
-0.7% -$2.5K 0.11% 146
2024
Q4
$335K Hold
434
– – 0.1% 146
2024
Q3
$385K Sell
434
-1
-0.2% -$899 0.12% 134
2024
Q2
$394K Sell
435
-5
-1% -$4K 0.15% 122
2024
Q1
$343K Sell
440
-21
-5% -$14.9K 0.14% 130
2023
Q4
$289K Buy
+461
New +$269K 0.13% 139

Other funds holding LLY

LongView Wealth Management's LLY Position: Q3 2026 in Review

LongView Wealth Management reduced its Eli Lilly (LLY) stake by 1.7% in Q3 2026, selling an estimated $3.54K and leaving 175 shares worth $202K. The position accounts for 0.05% of the portfolio, ranked #228.

LongView Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $498K in Q4 2025. 1,260 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • LongView Wealth Management held 175 shares of Eli Lilly worth $202K as of Q3 2026.
  • LongView Wealth Management sold 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
  • Eli Lilly made up 0.05% of LongView Wealth Management's portfolio in Q3 2026, its #228 holding.
  • LongView Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • LongView Wealth Management's Eli Lilly position peaked at $498K in Q4 2025.
  • 1,260 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on LongView Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.